Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia

In adult patients, acute lymphoblastic leukemia (ALL) is a rare hematological cancer with a cure rate below 50% and frequent relapses. With traditional therapies, patients with relapsed or refractory (R/R) ALL have a survival that may be measured in months; in these patients, inotuzumab ozogamicin (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravaioli, Federico, Marconi, Giovanni, Martinelli, Giovanni, Dajti, Elton, Sartor, Chiara, Abbenante, Maria Chiara, Alemanni, Luigina Vanessa, Nanni, Jacopo, Rossini, Benedetta, Parisi, Sarah, Colecchia, Luigi, Cristiano, Gianluca, Marasco, Giovanni, Vestito, Amanda, Paolini, Stefania, Bonifazi, Francesca, Curti, Antonio, Festi, Davide, Cavo, Michele, Colecchia, Antonio, Papayannidis, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817094/
https://www.ncbi.nlm.nih.gov/pubmed/34970853
http://dx.doi.org/10.1002/cam4.4390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817094/
https://www.ncbi.nlm.nih.gov/pubmed/34970853
http://dx.doi.org/10.1002/cam4.4390

Ejemplares similares